Davis Polk advised the representatives of the initial purchasers in connection with the offering. Bristol-Myers Squibb Company offered $19 billion in aggregate principal amount of senior…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
